View clinical trials related to Epilepsy.
Filter by:Open-label study in two parallel groups of 20 healthy subjects each. Group A assessed the effect of CBZ on ESL pharmacokinetics, and Group B assessed the effect of ESL on CBZ pharmacokinetics.
Single-blind, single-centre, fixed-order study to evaluate the PD effects of a single oral dose and multiple oral doses of ESL (BIA 2-093) in healthy volunteers.
Single center, randomized, single dose, laboratory-blinded, 2-period, 2-sequence, crossover design
Single centre, open-label, multiple doses, two parallel study groups each receiving two formulations in a one-sequence design
Single centre, open-label, multiple doses, one-sequence design study in two parallel groups of healthy volunteers
Single centre, open-label, multiple doses, one-sequence design study in two parallel groups of healthy volunteers
A randomized, double-blind, placebo-controlled and open label active-controlled, 4 period crossover trial to evaluate the effect of eslicarbazepine acetate on cardiac repolarization in healthy adult men and women
Single centre, open-label, randomised study in four parallel groups of healthy volunteers
Open-label, multiple-dose, single-centre study in 2 groups of subjects: subjects with moderate hepatic impairment and healthy controls. The trial consisted of a screening visit, a treatment phase and a follow-up visit. All subjects were to be treated with study medication for 8 consecutive days. Blood and urine were collected for the PK analysis, and safety assessments were performed.
Single centre, two-way crossover, randomised, open-label study in 20 healthy female volunteers.The volunteers received an oral single-dose of a combined contraceptive containing with an oral once daily dose of 1200 mg of BIA 2-093